Consumer DNA-testing company 23andMe is in talks to go public through a roughly $4 billion deal with VG Acquisition Corp., a SPAC founded by billionaire Richard Branson, Bloomberg reports.
A deal could be announced in the coming weeks if talks are successful, Bloomberg added, citing sources familiar with the talks. In funding rounds in both 2018 and 2020, 23andMe had a $2.5 billion valuation, separate sources told Bloomberg. Read more.
